Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems

Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems

Bibliographic Details
Main Authors:	Sukrit Silas, Patricia Lucas-Elio, Simon A Jackson, Alejandra Aroca-Crevillén, Loren L Hansen, Peter C Fineran, Andrew Z Fire, Antonio Sánchez-Amat
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2018-04-01
Series:	eLife
Online Access:	https://elifesciences.org/articles/36853

Similar Items

Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems
by: Sukrit Silas, et al.
Published: (2017-08-01)

Function and Regulation of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / CRISPR Associated (Cas) Systems
by: Peter C. Fineran, et al.
Published: (2012-10-01)

On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires
by: Sukrit Silas, et al.
Published: (2017-07-01)

Application of different types of CRISPR/Cas-based systems in bacteria
by: Zhenquan Liu, et al.
Published: (2020-09-01)

The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems
by: Fengtao Huang, et al.
Published: (2021-01-01)

In vivo protein interactions and complex formation in the Pectobacterium atrosepticum subtype I-F CRISPR/Cas System.
by: Corinna Richter, et al.
Published: (2012-01-01)

Positioning Diverse Type IV Structures and Functions Within Class 1 CRISPR-Cas Systems
by: Hannah N. Taylor, et al.
Published: (2021-05-01)

Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria
by: Aude Bernheim, et al.
Published: (2017-12-01)

Characterization of a Type II-A CRISPR-Cas System in Streptococcus mutans
by: Cas Mosterd, et al.
Published: (2020-06-01)

Incidence of Type II CRISPR1-Cas Systems in Enterococcus Is Species-Dependent.
by: Casandra Lyons, et al.
Published: (2015-01-01)

An Active Type I-E CRISPR-Cas System Identified in Streptomyces avermitilis.
by: Yi Qiu, et al.
Published: (2016-01-01)

Virus detection via programmable Type III-A CRISPR-Cas systems
by: Sagar Sridhara, et al.
Published: (2021-09-01)

Relationship of CRISPR-cas system with emm typing and erythromycin susceptibility in Streptococcus pyogenes
by: Po-XingZheng, et al.
Published: (2015)

The type I-E CRISPR-Cas system : Biology and applications of an adaptive immune system in bacteria
by: Amlinger, Lina
Published: (2017)

Structure of a type IV CRISPR-Cas ribonucleoprotein complex
by: Yi Zhou, et al.
Published: (2021-03-01)

Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24
by: Chen, Z., et al.
Published: (2022)

Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24
by: Chen, Z., et al.
Published: (2022)

The CRISPR-Cas system
by: Stens, Cassandra, et al.
Published: (2020)

Functional Features and Current Applications of the RNA‐Targeting Type VI CRISPR‐Cas Systems
by: Vanja Perčulija, et al.
Published: (2021-07-01)

On the Origin and Evolutionary Relationships of the Reverse Transcriptases Associated With Type III CRISPR-Cas Systems
by: Nicolás Toro, et al.
Published: (2018-06-01)

Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR–Cas system
by: Raymond H. J. Staals, et al.
Published: (2016-10-01)

Recruitment of Reverse Transcriptase-Cas1 Fusion Proteins by Type VI-A CRISPR-Cas Systems
by: Nicolás Toro, et al.
Published: (2019-09-01)

Multiplexed CRISPR-Cas9 system in a single adeno-associated virus to simultaneously knock out redundant clock genes
by: Boil Kim, et al.
Published: (2021-01-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

Repurposing the Native Type I-F CRISPR-Cas System in Pseudomonas aeruginosa for Genome Editing
by: Zeling Xu, et al.
Published: (2020-06-01)

Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity
by: Bridget N. J. Watson, et al.
Published: (2019-12-01)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
by: Gilles Darcis, et al.
Published: (2019-03-01)

Development of both type I–B and type II CRISPR/Cas genome editing systems in the cellulolytic bacterium Clostridium thermocellum
by: Julie E. Walker, et al.
Published: (2020-06-01)

Type II CRISPR/Cas9 approach in the oncological therapy
by: A. Biagioni, et al.
Published: (2017-06-01)

Cas1 and Cas2 From the Type II-C CRISPR-Cas System of Riemerella anatipestifer Are Required for Spacer Acquisition
by: Yang He, et al.
Published: (2018-06-01)

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
by: Lucy Chou-Zheng, et al.
Published: (2019-04-01)

Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts
by: Gregory W. Goldberg, et al.
Published: (2018-01-01)

RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System.
by: Tina Y Liu, et al.
Published: (2017-01-01)

Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in Staphylococcus aureus
by: Jing Guan, et al.
Published: (2017-11-01)

Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
by: Yuxi Chen, et al.
Published: (2020-06-01)

CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
by: Zhen Wang, et al.
Published: (2016-04-01)

Drug Inducible CRISPR/Cas Systems
by: Jingfang Zhang, et al.
Published: (2019-01-01)

Applications of CRISPR-Cas systems in neuroscience
by: Heidenreich, Matthias, et al.
Published: (2017)

Wild-type Drosophila melanogaster as an alternative model system for investigating the pathogenicity of Candida albicans
by: Marcus T. Glittenberg, et al.
Published: (2011-07-01)

Programmable type III-A CRISPR-Cas DNA targeting modules.
by: H Travis Ichikawa, et al.
Published: (2017-01-01)